chr11-31539674-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP5BS2_Supporting
The NM_019040.5(ELP4):āc.272A>Gā(p.Tyr91Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000934 in 1,606,052 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (no stars).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 32)
Exomes š: 0.0000069 ( 0 hom. )
Consequence
ELP4
NM_019040.5 missense
NM_019040.5 missense
Scores
2
11
6
Clinical Significance
Conservation
PhyloP100: 5.17
Genes affected
ELP4 (HGNC:1171): (elongator acetyltransferase complex subunit 4) This gene encodes a component of the six subunit elongator complex, a histone acetyltransferase complex that associates directly with RNA polymerase II during transcriptional elongation. The human gene can partially complement sensitivity phenotypes of yeast ELP4 deletion mutants. This gene has also been associated with Rolandic epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PP5
Variant 11-31539674-A-G is Pathogenic according to our data. Variant chr11-31539674-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1328942.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 5 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ELP4 | NM_019040.5 | c.272A>G | p.Tyr91Cys | missense_variant | 3/10 | ENST00000640961.2 | NP_061913.3 | |
ELP4 | NM_001288726.2 | c.272A>G | p.Tyr91Cys | missense_variant | 3/12 | NP_001275655.1 | ||
ELP4 | NM_001288725.2 | c.272A>G | p.Tyr91Cys | missense_variant | 3/11 | NP_001275654.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ELP4 | ENST00000640961.2 | c.272A>G | p.Tyr91Cys | missense_variant | 3/10 | 1 | NM_019040.5 | ENSP00000492152 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152170Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000573 AC: 14AN: 244216Hom.: 0 AF XY: 0.0000604 AC XY: 8AN XY: 132348
GnomAD3 exomes
AF:
AC:
14
AN:
244216
Hom.:
AF XY:
AC XY:
8
AN XY:
132348
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000688 AC: 10AN: 1453764Hom.: 0 Cov.: 30 AF XY: 0.00000692 AC XY: 5AN XY: 722694
GnomAD4 exome
AF:
AC:
10
AN:
1453764
Hom.:
Cov.:
30
AF XY:
AC XY:
5
AN XY:
722694
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152288Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74460
GnomAD4 genome
AF:
AC:
5
AN:
152288
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
6
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Seizure;C0338656:Cognitive impairment;C0557874:Global developmental delay Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | Wainwright Lab, University Of Queensland | - | The variant is inherited in compound heterozygosity: c.886C>A (p.Leu296Ile) (inherited from mother) and c.272A>G (p.Tyr91Cys) (inherited from the father). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;.;.;.;.;.;.;.;.;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;M;.;.;.;.;.;.;.;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;.;D;.;D;.;.;.;.;.;.;D
REVEL
Uncertain
Sift
Uncertain
.;.;D;.;D;.;.;.;.;.;.;D
Sift4G
Uncertain
.;.;D;.;D;.;.;.;.;.;.;D
Polyphen
D;.;.;.;.;.;.;.;.;.;.;D
Vest4
0.71, 0.68, 0.67
MutPred
Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);Loss of ubiquitination at K90 (P = 0.0795);
MVP
0.72
MPC
0.36
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at